OCYTOCIN

Year closed	Due by	Filed	Variance	Reference
31-12-2025	31-07-2026	nothing on record	not filed	-
31-12-2024	31-07-2025	30-07-2025	1 d early	2025-00360124
31-12-2023	31-07-2024	24-07-2024	7 d early	2024-00279807
31-12-2022	31-07-2023	31-08-2023	31 d late	2023-00423079
31-12-2021	31-07-2022	28-07-2022	3 d early	2022-20250931
31-12-2020	31-07-2021	29-07-2021	2 d early	2021-43000286

Metric	This company	Sector median	Position in the sector
Solvency	64.7%	60.6%	better than 55% of 12463 sector peers
Net result	€-4k	€31k	better than 11% of 12465 sector peers
Equity	€162k	€63k	better than 80% of 12471 sector peers
Gross operating margin	€21k	€52k	better than 26% of 12451 sector peers
Total assets	€251k	€124k	better than 75% of 12464 sector peers

Line item	Code	2024
Balance sheet, Assets
TOTAL ASSETS	20/58	€251k
Fixed assets	21/28	€158k
Tangible fixed assets	22/27	€158k
Current assets	29/58	€93k
Amounts receivable within one year	40/41	€81k
Cash & bank	54/58	€10k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€251k
Equity	10/15	€162k
Contributions / capital	10/11	€5k
Accumulated profits (losses)	14	€157k
Amounts payable	17/49	€88k
Amounts payable within one year	42/48	€88k
Trade debts payable within one year	44	€7k
Income statement
Gross operating margin	9900	€21k
Operating result	9901	€-4k
Financial charges	65	€152
Result before taxes	9903	€-4k
Net result for the period	9904	€-4k
Result to be appropriated	9905	€-4k

Summary